The Association of the British Pharmaceutical Industry is standing by its code of practice after a study found that self-regulation in the UK was ineffective in preventing company misconduct, with the situation being even worse in most other parts of Europe.
Severe Misconduct, Repeat Offending And Underreporting: UK/EU Codes Come Under Fire
The UK and EU pharma industry associations have defended their respective codes of practice despite alarming study results. Meanwhile, a consultation on proposals to revise the UK code received over 3,500 comments.
